Our Montreal office advised NeuroRx Research Inc. and its group companies (NeuroRx) in a complex transaction in which NeuroRx was acquired by Clario, a transaction that will enable NeuroRx to expand its reach, increase innovation and broaden its impact on drug development.

NeuroRx is an imaging provider with unparalleled expertise in diseases impacting the central nervous system, and Clario is a leading provider of endpoint data solutions to the clinical trials industry. 

Beratungsfelder:

Branchenschwerpunkte: